QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Heron Therapeutics (HRTX) Earnings Date, Estimates & Call Transcripts

$2.60
0.00 (0.00%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

HRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Heron Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.90) EPS
Next Year EPS Consensus Estimate: ($0.48) EPS

HRTX Earnings Date and Information

Heron Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off prior year's report dates.

Heron Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/28/2024
Estimated)
------- 
11/14/2023Q3 2023($0.31)($0.17)+$0.14($0.17)$31.63 million$31.43 million
8/14/2023Q2 2023($0.23)($0.35)($0.12)($0.35)$31.75 million$31.76 million    
5/11/2023Q1 2023($0.17)($0.27)($0.10)($0.27)$28.30 million$29.62 million
3/23/2023Q4 2022($0.25)($0.17)+$0.08($0.17)$27.24 million$30.00 million    
11/8/2022Q3 2022($0.39)($0.38)+$0.01($0.38)$26.23 million$26.56 million
8/9/2022Q2 2022($0.50)($0.55)($0.05)($0.55)$24.65 million$27.63 million    
5/9/2022Q1 2022($0.45)($0.63)($0.18)($0.63)$22.61 million$23.46 million    
2/28/2022Q4 2021($0.59)($0.54)+$0.05($0.54)$25.77 million$20.66 million    
11/3/2021Q3 2021($0.60)($0.51)+$0.09($0.51)$25.04 million$23.23 million    
8/9/2021Q2 2021($0.56)($0.62)($0.06)($0.62)$28.44 million$22.44 million
5/10/2021Q1 2021($0.57)($0.58)($0.01)($0.58)$26.00 million$20.10 million












Heron Therapeutics Earnings - Frequently Asked Questions

When is Heron Therapeutics's earnings date?

Heron Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off last year's report dates. Learn more on HRTX's earnings history.

How much revenue does Heron Therapeutics generate each year?

Heron Therapeutics (NASDAQ:HRTX) has a recorded annual revenue of $107.67 million.

How much profit does Heron Therapeutics generate each year?

Heron Therapeutics (NASDAQ:HRTX) has a recorded net income of -$182.02 million. HRTX has generated -$0.96 earnings per share over the last four quarters.

What is Heron Therapeutics's EPS forecast for next year?

Heron Therapeutics's earnings are expected to grow from ($0.90) per share to ($0.48) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:HRTX) was last updated on 2/26/2024 by MarketBeat.com Staff